NOBEL BIOCARE DANMARK A/S: Financial statements 2019
CVR: 28293364
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 3,951,270 and a net result of DKK -5,470,814 compared with DKK 419,851 the year before. That is an increase of 18.4% compared with the year before. Equity in the 2019 report amounted to DKK -615,663. The company had 4 employees in the financial year.
- Gross Profit
- DKK 3,951,270
- Profit/Loss
- DKK -5,470,814
- Equity
- DKK -615,663
- Total Assets
- DKK 383,694,209
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 4M | -5.5M | -616K | 4 |
| 2018 | - | 3.3M | 420K | 4.9M | 3 |
| 2017 | - | 3.8M | 580K | 4.4M | 4 |
| 2016 | - | 6.3M | 894K | 3.9M | 4 |
| 2015 | - | 5.5M | 578K | 3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NOBEL BIOCARE DANMARK A/S has published its annual report for 2018. Gross profit came to DKK 3,336,703, and the net result was DKK 419,851.
As of January 9, 2019, Hans Braunstein has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 9, 2019, Hans Tobias Nordefjäll has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 9, 2019, Jens Henrik Nedoh has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 9, 2019, Hans Braunstein is registered as director of NOBEL BIOCARE DANMARK A/S.
As of January 9, 2019, Jens Henrik Nedoh has stepped down as director of NOBEL BIOCARE DANMARK A/S.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.